简介
Professor Barry Halliwell is Senior Advisor, Academic Appointments and Research Excellence, Office of the Provost, at the National University of Singapore (NUS). Prof Halliwell is also Chairman of the Biomedical Research Advisory Council (BMAC), A*STAR.
Professor Halliwell graduated from the University of Oxford with Bachelor of Arts (first class honours) and Doctor of Philosophy degrees. He holds a Doctor of Science degree from the University of London. He was a faculty member with the University of London, King’s College from 1974 to 2000 and held a prestigious Lister Institute Research fellowship. From 1995 to 1999, he was a Visiting Research Professor of Internal Medicine and Biochemistry with the University of California Davis, School of Medicine, Divisions of Cardiology and Pulmonary/Critical Care Medicine. Professor Halliwell was a Visiting Professor of Biochemistry to NUS from 1998 to 2000. He was Head of the University’s Department of Biochemistry from 2003 to 2007 and was Deputy Director, Office of Life Sciences from 2001 to 2005. From 2003 to September 2008, he was the founding Executive Director of the NUS Graduate School of Integrative Sciences and Engineering. He was Deputy President (Research and Technology) at NUS from 2006 to May 2015. From Jun 2015 to May 2018, he was the Senior Advisor to the President at the National University of Singapore. From March 2016 to end May 2016, he was a Visiting Professor at University College London, and is now a Visiting Professor at Imperial College London.
An internationally acclaimed biochemist, Professor Halliwell is known especially for his seminal work on the role of free radicals and antioxidants in biological systems. The Thomson Reuters lists Professor Halliwell as one of the world’s most highly-cited researchers in Neurobiology & Behaviour, Pharmacology & Toxicology, Biology and Biochemistry, and his Hirsch Index is 170 (Based on Scopus, Jan 2024). His first-authored book with John Gutteridge Free Radicals in Biology and Medicine published by Oxford University Press, and now in its fifth edition (completely revised and expanded), published 2015, is regarded worldwide as the authoritative text in the field and has been cited above 34906 times (based on Google Scholar, Jan 2024).
Professor Halliwell was awarded the Public Administration Medal (Silver) in 2010 by the President of Singapore for contributions to Singapore and awarded the President’s Science and Technology Medal 2013 by the President of Singapore “for distinguished sustained and exceptional contributions to Singapore’s Science and Engineering landscape”. He was awarded the “Lifetime Achievement Award” by the Society for Free Radical Biology and Medicine in the USA for overall sustained excellence in the field. He was also awarded the Ken Bowman Research Award for outstanding achievements in the field of cardiovascular research from the Institute of Cardiovascular Sciences (Canada) and NUS University Award – Outstanding Researcher Award. Professor Halliwell was awarded a Doctor of Science honoris causa by King’s College London in 2018. In 2018, he was again identified as a “Highly Cited Scientist” for cross-disciplinary work by Clarivate Analytics. More recently, Prof Halliwell was invited to give a special award lecture “Reflections of an Ageing Free Radical” at the 20th Biennial Meeting for the Society for Free Radical Research International (SFRRI 2020) in Taiwan in March 2021. He was honoured as a Citation Laureate (2021) for pioneering research in free-radical chemistry including the role of free radicals and antioxidants in human disease. The distinction is awarded by information and insights company Clarivate to researchers whose work has been deemed to be of “Nobel Class” as they are among the most highly cited and influential, even transformative, in their fields. Citation Laureate candidates are selected from authors of the 0.01 per cent of some 52 million articles and proceedings that have been cited 2,000 times or more. He was one of 16 scientists (one of three in Chemistry) around the world listed in the Hall of Citation Laureates for 2021.
His research focuses on the role of free radicals and antioxidants in human disease, particularly Alzheimer disease and other brain disorders, such as strokes, and in the ageing process. His interest in identifying the most important antioxidants in the human diet and in developing novel antioxidants has critical bearing on treating human diseases and understanding how diet might cause or prevent them.
Professor Halliwell is a member of several editorial boards including FEBS Letters and Antioxidants and Redox Signaling. He has been a lead speaker at Gordon Conferences and other prestigious events worldwide and is a member of several expert advisory panels to leading universities, companies and government agencies.
